Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Risk Mitigation and Its Impact on Pharma Marketing

  • Broadcast in Business
Pharmaguy

Pharmaguy

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharmaguy.
h:755
s:696598
archived
Play
  • Host
A conversation with Jeff Fetterman, President and CEO of ParagonRx, about developing a Risk Evaluation and Mitigation Strategy (REMS) that clinicians will consider useful and that would raise their intent to prescribe.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled